- Home
- Publications
- Publication Search
- Publication Details
Title
Precision medicine: from pharmacogenomics to pharmacoproteomics
Authors
Keywords
Pharmacogenomics, Proteomics, Biomarker, Precision medicine
Journal
Clinical Proteomics
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-26
DOI
10.1186/s12014-016-9127-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
- (2016) Hui Zhang et al. CELL
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- DNA Methylation of ADME Genes
- (2016) P Fisel et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment
- (2016) Desirée Hao et al. Metabolomics
- Pharmacometabolomics informs pharmacogenomics
- (2016) Drew Neavin et al. Metabolomics
- Proteogenomics connects somatic mutations to signalling in breast cancer
- (2016) Philipp Mertins et al. NATURE
- Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer
- (2016) Gianmaria Miolo et al. Oncotarget
- Pharmacogenomic Determinants of the Cardiovascular Effects of DalcetrapibCLINICAL PERSPECTIVE
- (2015) Jean-Claude Tardif et al. Circulation-Cardiovascular Genetics
- Ambient Ionization Mass Spectrometry for Point-of-Care Diagnostics and Other Clinical Measurements
- (2015) C. R. Ferreira et al. CLINICAL CHEMISTRY
- Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine
- (2015) R Kaddurah-Daouk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The second coming of epigenetic drugs: A more strategic and broader research framework could boost the development of new drugs to modify epigenetic factors and gene expression
- (2015) P. Hunter EMBO REPORTS
- Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma
- (2015) Rebecca L. Goldstein et al. JOURNAL OF CLINICAL INVESTIGATION
- FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing
- (2015) Kenneth D. Levy et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vitro human cell line models to predict clinical response to anticancer drugs
- (2015) Nifang Niu et al. PHARMACOGENOMICS
- Genome-wide association studies in pharmacogenomics of antidepressants
- (2015) Eugene Lin et al. PHARMACOGENOMICS
- Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy
- (2015) S Cao et al. PHARMACOGENOMICS JOURNAL
- Senate panel approves $2 billion raise for NIH in 2016
- (2015) Jocelyn Kaiser SCIENCE
- Pharmacogenomic Determinants of the Cardiovascular Effects of DalcetrapibCLINICAL PERSPECTIVE
- (2015) Jean-Claude Tardif et al. Circulation-Cardiovascular Genetics
- Current Developments in Activity-Based Protein Profiling
- (2014) Lianne I. Willems et al. BIOCONJUGATE CHEMISTRY
- Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens
- (2014) DaRue A Prieto et al. Biomarkers in Medicine
- Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations
- (2014) Yuan Ji et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Quantitative targeted proteomics for understanding the blood–brain barrier: towards pharmacoproteomics
- (2014) Sumio Ohtsuki et al. Expert Review of Proteomics
- Multiple evidence strands suggest that there may be as few as 19 000 human protein-coding genes
- (2014) Iakes Ezkurdia et al. HUMAN MOLECULAR GENETICS
- Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to theUGT1A1Genotype of Patients With Cancer
- (2014) Federico Innocenti et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA methylation and personalized medicine
- (2014) J. Tang et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Quantitative Chemical Proteomics Identifies Novel Targets of the Anti-cancer Multi-kinase Inhibitor E-3810
- (2014) Mara Colzani et al. MOLECULAR & CELLULAR PROTEOMICS
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Pharmaco-proteomics opportunities for individualizing neurovascular treatment
- (2014) M M Ning et al. NEUROLOGICAL RESEARCH
- Pharmacogenomic biomarkers in drug labels: what do they tell us?
- (2014) Richard Tutton PHARMACOGENOMICS
- Proteomics in mechanistic toxicology: History, concepts, achievements, caveats, and potential
- (2014) Thierry Rabilloud et al. PROTEOMICS
- Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib
- (2014) N. Wagle et al. Cancer Discovery
- Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer
- (2013) Hiltrud Brauch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
- (2013) R Kaddurah-Daouk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Integrated Analysis of Transcriptomic and Proteomic Data
- (2013) Saad Haider et al. CURRENT GENOMICS
- Pharmacogenomics of lipid-lowering therapies
- (2013) Miao Hu et al. PHARMACOGENOMICS
- Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed
- (2013) H. L. McLeod SCIENCE
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- How Chemoproteomics Can Enable Drug Discovery and Development
- (2012) Raymond E. Moellering et al. CHEMISTRY & BIOLOGY
- FIRST PHARMACOGENOMIC ANALYSIS USING WHOLE EXOME SEQUENCING TO IDENTIFY NOVEL GENETIC DETERMINANTS OF CLOPIDOGREL RESPONSE VARIABILITY: RESULTS OF THE GENOTYPE INFORMATION AND FUNCTIONAL TESTING (GIFT) EXOME STUDY
- (2012) Matthew J. Price et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Phosphosignature Predicts Dasatinib Response in Non-small Cell Lung Cancer
- (2012) Martin Klammer et al. MOLECULAR & CELLULAR PROTEOMICS
- Cancer pharmacogenomics: strategies and challenges
- (2012) Heather E. Wheeler et al. NATURE REVIEWS GENETICS
- Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
- (2012) C Fernandez-Rozadilla et al. PHARMACOGENOMICS JOURNAL
- Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity
- (2012) Anke Van Summeren et al. TOXICOLOGY IN VITRO
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Deep proteome and transcriptome mapping of a human cancer cell line
- (2011) N. Nagaraj et al. Molecular Systems Biology
- The quantitative proteome of a human cell line
- (2011) M. Beck et al. Molecular Systems Biology
- Selective killing of cancer cells by a small molecule targeting the stress response to ROS
- (2011) Lakshmi Raj et al. NATURE
- Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation
- (2011) Heather E Wheeler et al. PHARMACOGENOMICS
- Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line
- (2010) Christine Vogel et al. Molecular Systems Biology
- Genome-wide association studies in pharmacogenomics
- (2010) Alison A. Motsinger-Reif et al. Pharmacogenetics and Genomics
- Repeatability and Reproducibility in Proteomic Identifications by Liquid Chromatography−Tandem Mass Spectrometry
- (2009) David L. Tabb et al. JOURNAL OF PROTEOME RESEARCH
- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
- (2009) Terri A Addona et al. NATURE BIOTECHNOLOGY
- Target profiling of small molecules by chemical proteomics
- (2009) Uwe Rix et al. Nature Chemical Biology
- Pharmacogenomic Discovery Using Cell-Based Models
- (2009) M. Welsh et al. PHARMACOLOGICAL REVIEWS
- Identifying the proteins to which small-molecule probes and drugs bind in cells
- (2009) S.-E. Ong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
- (2008) Ulrich M. Zanger et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays
- (2008) J. C. Marioni et al. GENOME RESEARCH
- RNA-Seq: a revolutionary tool for transcriptomics
- (2008) Zhong Wang et al. NATURE REVIEWS GENETICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P450 and Chemical Toxicology
- (2007) F. Peter Guengerich CHEMICAL RESEARCH IN TOXICOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now